down arrow

Bafna Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE878I01022
  • NSEID: BAFNAPH
  • BSEID: 532989
  • View on NSE | View on BSE
INR
107.50
-1.4 (-1.29%)
BSENSE

Mar 05

BSE+NSE Vol: 11.74 k

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'19
Jun'19
Sep'18
Net Sales
11.57
6.85
8.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
11.57
6.85
8.84
Raw Material Cost
8.84
6.95
5.32
Purchase of Finished goods
0.00
0.00
0.16
(Increase) / Decrease In Stocks
0.02
-0.60
0.17
Employee Cost
2.43
2.31
2.18
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.65
1.06
0.83
Total Expenditure (Excl Depreciation)
11.94
9.71
8.66
Operating Profit (PBDIT) excl Other Income
-0.37
-2.86
0.18
Other Income
0.59
0.30
-0.03
Operating Profit (PBDIT)
0.22
-2.56
0.15
Interest
0.04
0.13
0.62
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
0.18
-2.69
-0.47
Depreciation
0.72
1.02
0.75
Profit Before Tax
-0.55
-3.71
-1.22
Tax
0.04
-1.58
0.05
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-0.59
-2.13
-1.28
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-0.59
-2.13
-1.28
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.59
-2.13
-1.28
Equity Capital
23.66
23.66
23.66
Face Value
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
-0.25
-0.9
-0.54
Diluted Earnings per share
-0.25
-0.9
-0.8
Operating Profit Margin (Excl OI)
-3.2%
-41.75%
2.04%
Gross Profit Margin
1.56%
-39.27%
-5.32%
PAT Margin
-5.1%
-31.09%
-14.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 7.95% vs 2.46% in Sep 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -41.03% vs -7.96% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -28.74% vs -15.42% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 0.00% vs -5.49% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Bafna Pharma. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
11.57
0
11.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
11.57
0
11.57
Raw Material Cost
8.84
0
8.84
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.02
0
0.02
Employee Cost
2.43
0
2.43
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
0.65
0.00
0.65
Total Expenditure (Excl Depreciation)
11.94
0
11.94
Operating Profit (PBDIT) excl Other Income
-0.37
0.00
-0.37
Other Income
0.59
0
0.59
Operating Profit (PBDIT)
0.22
0
0.22
Interest
0.04
0
0.04
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.18
0
0.18
Depreciation
0.72
0
0.72
Profit Before Tax
-0.55
0
-0.55
Tax
0.04
0
0.04
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-0.59
0
-0.59
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-0.59
0
-0.59
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.59
0
-0.59
Equity Capital
23.66
0
23.66
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
-0.25
0
-0.25
Diluted Earnings per share
-0.25
0
-0.25
Operating Profit Margin (Excl OI)
-3.20%
0%
0.00
-3.20%
Gross Profit Margin
1.56%
0%
0.00
1.56%
PAT Margin
-5.10%
0%
0.00
-5.10%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.29 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 7.95% vs 2.46% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 15.37% vs 16.70% in Dec 2024

Quarterly - Standalone Net Profit
Standalone Net Profit 1.84 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -41.03% vs -7.96% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 93.68% vs 132.31% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.05 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -28.74% vs -15.42% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -0.65% vs 247.60% in Dec 2024

Quarterly - Interest
Interest 0.86 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs -5.49% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 34.37% vs 10.34% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.97%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."